Faculty

Joshua Berlin
Executive Director, New Ventures,
BioCentury Inc.
Karen Bernstein, Ph.D.
Chairman,
BioCentury Inc.
Kate Bingham
Managing Partner,
SV Health Investors
Paul Bonanos
Associate Editor,
BioCentury Inc.
Michael Booth, Ph.D.
CFO,
Crescendo Biologics Ltd.
Simone Botti, Ph.D.
Junior Partner,
Inkef Capital
Eduardo Bravo
CEO,
European Biotech Acquisition Corp.
Sascha-Oliver Bucher
Co-founder & Partner,
Forty51 Ventures
Roel Bulthuis
Managing Partner & Head of Healthcare Investment,
Inkef Capital
Simon Chandler, Ph.D.
CEO,
Rinri Therapeutics Ltd.
Tony Chen
Chairman,
BayHelix & Partner, Jones Day
Jeffrey Cranmer
Executive Editor, BioCentury Inc. & Host, "BioCentury This Week" Podcast,
BioCentury Inc.
Sabine Dandiguian
Managing Partner,
Jeito Capital
Jan De Kerpel, Ph.D.
Managing Director,
Kempen & Co.
Cris De Luca
Global Head, Digital Investments,
Sanofi Ventures
Valerio De Molli
Managing Partner & CEO,
The European House - Ambrosetti
Francesco De Rubertis Ph.D.
Co-Founder & Partner,
Medicxi
David Dobkin
Managing Director, LifeSci Capital, and CFO, LifeSci Acquisition Corp. and LifeSci Acquisition II Corp.,
LifeSci Capital
Sergio Dompé
CEO,
Dompé farmaceutici, and Chair, B20 Task Force Health and Life Sciences
Simone Fishburn, Ph.D.
Vice President and Editor in Chief,
BioCentury Inc.
David Flores
President & CEO,
BioCentury Inc.
Arthur Franken
General Partner,
Gilde Healthcare
Aoife Gallagher, Ph.D.
Head of Innovation,
RCSI University of Medicine and Health Sciences
Robert Garber
Partner,
7wireVentures
Taylor Guo, Ph.D.
Chief Scientific Officer,
I-Mab Biopharma Co.
Stephen Hansen
Associate Editor,
BioCentury Inc.
Theodora Harold
CEO,
Crescendo Biologics
Wei-Wu He, Ph.D.
Chairman & CEO,
CASI Pharmaceuticals Inc.
Rudiger Herrmann, Ph.D.
Partner,
Squire Patton Boggs
Echo Hindle-Yang
Founder & CEO,
MSQ Ventures
Will Hoh
Managing Director, Investment Banking, M&A and Strategic Advisory Services,
H.C. Wainwright & Co.
Steve Hurly
CEO,
Lava Therapeutics N.V.
Alicia Irurzun-Lafitte
Partner,
UCB Ventures
Derek John, Ph.D.
Technology Transfer Case Manager,
RCSI University of Medicine and Health Sciences
Henk Joos, Ph.D.
General Manager,
Agio Capital & Business Solutions
Frank Kalkbrenner, Ph.D.
Global Head,
Boehringer Ingelheim Venture Fund
Dirk Kersten
General Partner,
Forbion
Michael Keyoung, M.D., Ph.D.
Managing Director & Head of North America,
CBC Group
David Klein
CEO,
Click Therapeutics Inc.
Selina Koch, Ph.D.
Executive Editor,
BioCentury Inc.
Sophie Kornowski, Pharm.D.
Senior Partner,
Gurnet Point Capital
Arthur Lahr
Former CEO,
Kiadis Pharma N.V.
Werner Lanthaler, Ph.D.
CEO,
Evotec AG
Virginia Li
Associate Editor,
BioCentury Inc.
Andrew Limouris
CEO,
Medix
Carsten Linnemann, Ph.D.
Co-founder, President & CEO,
Neogene Therapeutics Inc.
Da Liu
Managing Director,
CR-CP Life Science Fund
Alberto Loche, Ph.D.
Associate Partner,
McKinsey & Co.
William Love, Ph.D.
Founder & Chief Scientific Officer,
Destiny Pharma Ltd.
Anker Lundemose, M.D., Ph.D.
CEO,
Mission Therapeutics Ltd.
Nanna Luneborg, Ph.D.
Partner,
Novo Ventures
Vanessa Malier
Partner,
Kurma Partners
Allan Marchington, Ph.D.
Managing Director & Head of Life Sciences,
Intermediate Capital Group plc
Lauren Martz
Senior Editor, Head, Translation & Clinical Development,
BioCentury Inc.
Anant Murthy, Ph.D.
General Manager Europe,
argenx S.E.
Carole Nuechterlein
Head, Roche Venture Fund,
Roche
Alan O'Connell, Ph.D.
Partner,
Seroba
Stefan Oelrich
Head, Pharmaceuticals,
Bayer AG
Anne Osdoit
Partner,
Sofinnova Partners
Antoine Papiernik
Chairman and Managing Partner,
Sofinnova Partners
Eric Pierce
Publisher,
BioCentury Inc.
Steven Powell, Ph.D.
CEO,
eTheRNA immunotherapies N.V.
Pam Putz
Managing Director,
EBD Group
John Rex, M.D.
Chief Medical Officer & Director, F2G Ltd. and Editor in Chief, AMR Solutions,
F2G Ltd.
Henrijette Richter, Ph.D.
Managing Partner,
Sofinnova Partners
Joachim Rothe, Ph.D.
Managing Partner,
LSP
Giuseppe Sala
Mayor of Milan,
Milan, Italy
Jorge Santos da Silva, Ph.D.
Senior Partner,
McKinsey & Company
Graziano Seghezzi
Managing Partner,
Sofinnova Partners
Henry Skinner, Ph.D.
CEO,
AMR Action Fund
Jeff Smith
Partner & Global Leader, Cell & Gene Therapy,
McKinsey & Co.
Bobby G. Soni, Ph.D.
CBO,
BioInnovation Institute
Karen Tkach Tuzman, Ph.D.,
Senior Editor & Head, Discovery & Preclinical Research,
BioCentury Inc.
Rafaèle Tordjman, M.D., Ph.D.
Founder & CEO,
Jeito Capital
Andreas Typaldos
CEO,
Petra Acquisition Inc.
Marina Udier, Ph.D.
CEO,
Nouscom AG
Steve Usdin
Senior Editor & Head Policy and Regulation,
BioCentury Inc.
Mark Vaeck, Ph.D.
CEO,
Complix N.V.
Jerome Van Biervliet, Ph.D.
Managing Director,
VIB
Benoît van den Hove
Head of Listing, Belgium,
Euronext
Lieven Van der Veken, M.D.
Senior Partner,
McKinsey & Co.
Vincent Van Dessel
CEO,
Euronext Brussels
Tim Van Hauwermeiren
CEO,
argenx S.E.
Guillaume Vignon
SVP, Business Development,
BeiGene Ltd.
Evelina Vågesjö, Ph.D.
Co-founder & CEO,
Ilya Pharma AB
Mark Wegter
Managing Partner,
LSP Partners
Martin Welschof, Ph.D.
CEO,
BioInvent International AB
Erica Whittaker, Ph.D.
Head,
UCB Ventures
Kathleen M. Williams, Ph.D.
Co-Chair, Life Sciences,
Nutter McClennen & Fish LLP
Marta-Gaia Zanchi, Ph.D.
Managing Partner,
Nina Capital
Alexandra Zemp, Ph.D.
Partner,
McKinsey & Company